BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2362794)

  • 1. [Clinical results of conventional fractionation radiotherapy for glottic and supraglottic laryngeal cancers--the usefulness of hyperfractionation for these cancers].
    Masunaga S; Ono K; Tsutsui K; Abe M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Feb; 50(2):139-45. PubMed ID: 2362794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of early glottic and supraglottic carcinoma treated with conventional fractionation of radiotherapy.
    Inoue T; Inoue T; Ikeda H; Teshima T; Yamazaki H; Murayama S; Othani M; Ozeki S
    Strahlenther Onkol; 1993 Oct; 169(10):584-9. PubMed ID: 8235982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Definitive radiation therapy for moderately advanced laryngeal cancer: effects of accelerated hyperfractionation.
    Okubo M; Nishimura Y; Shibata T; Nakamatsu K; Kanamori S; Tachibana I; Koike R; Nishikawa T; Mori K
    Jpn J Clin Oncol; 2010 Oct; 40(10):944-8. PubMed ID: 20534687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperfractionated accelerated radiotherapy for T1,2 glottic carcinoma. Consideration of time-dose factors.
    Sakata K; Someya M; Hori M; Nakata K; Takagi M; Hareyama M
    Strahlenther Onkol; 2008 Jul; 184(7):364-9. PubMed ID: 19016035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radical radiotherapy for T3 laryngeal cancers.
    Uno T; Itami J; Kotaka K; Toriyama M
    Strahlenther Onkol; 1996 Aug; 172(8):422-6. PubMed ID: 8765344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The management of glottic and supraglottic cancers of the larynx in relation to neck metastasis.
    Yücetürk AV; Celik O; Eskiizmir G
    Kulak Burun Bogaz Ihtis Derg; 2003 Nov; 11(5):129-33. PubMed ID: 15542939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative estimation of cure rates for supraglottic and glottic cancer in radiotherapy.
    Goleń M; Składowski K; Maciejewski B
    Neoplasma; 1999; 46(1):66-71. PubMed ID: 10355537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Early stages of laryngeal cancer (I-II stage) and therapeutic options: case report and review of literature].
    Margarino G; Schenone G; Scala M; Mereu P; Comandini D; Corvo R; Scolaro T; Badellino F
    Acta Otorhinolaryngol Ital; 1996 Feb; 16(1):40-6. PubMed ID: 8984839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiotherapy for T1 and T2 laryngeal cancer: the Dalhousie University experience.
    Hafidh M; Tibbo J; Trites J; Corsten G; Hart RD; Nasser J; Wilke D; Mark Taylor S
    J Otolaryngol Head Neck Surg; 2009 Aug; 38(4):434-9. PubMed ID: 19755083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic outcomes of laryngeal cancer at Kyoto University Hospital for 10 years.
    Tamura Y; Tanaka S; Asato R; Hirano S; Yamashita M; Tamaki H; Ito J
    Acta Otolaryngol Suppl; 2007 Feb; (557):62-5. PubMed ID: 17453448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial laryngectomy after irradiation failure.
    Yiotakis J; Stavroulaki P; Nikolopoulos T; Manolopoulos L; Kandiloros D; Ferekidis E; Adamopoulos G
    Otolaryngol Head Neck Surg; 2003 Feb; 128(2):200-9. PubMed ID: 12601315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of early laryngeal cancers (T1-T2 N0): surgery or irradiation?
    Jones AS; Fish B; Fenton JE; Husband DJ
    Head Neck; 2004 Feb; 26(2):127-35. PubMed ID: 14762881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of accelerated fractionated irradiation for supraglottic carcinoma: assessment of results.
    Wang CC; Nakfoor BM; Spiro IJ; Martins P
    Cancer J Sci Am; 1997; 3(2):88-91. PubMed ID: 9099458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotherapy of laryngeal cancer. General principles and results in T1 and T2 cases.
    De Schryver A
    Acta Otorhinolaryngol Belg; 1992; 46(2):187-95. PubMed ID: 1605021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour volume: implications in T2/T3 glottic/supraglottic squamous cell carcinoma.
    Lo SM; Venkatesan V; Matthews TW; Rogers J
    J Otolaryngol; 1998 Oct; 27(5):247-51. PubMed ID: 9800621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Radiation treatment of early stage supraglottic cancer].
    Spriano G; Ferrario F; Roselli R; Piantanida R; Antognoni P
    Ann Otolaryngol Chir Cervicofac; 1999 May; 116(2):66-70. PubMed ID: 10378034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiotherapy for patients with early-stage glottic carcinoma: univariate and multivariate analyses in a group of consecutive, unselected patients.
    Franchin G; Minatel E; Gobitti C; Talamini R; Vaccher E; Sartor G; Politi D; Trovò MG; Barzan L
    Cancer; 2003 Aug; 98(4):765-72. PubMed ID: 12910521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Radiotherapy of laryngeal carcinoma (T1a/b excluding glottic cancer). Critical review of the literature and personal experience].
    Gabriele P; Orecchia R
    Radiol Med; 1991 Mar; 81(3):320-6. PubMed ID: 2014340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation therapy in early glottic carcinoma: significance of prognostic factors and dose fractionation.
    Dinshaw KA; Sharma V
    Indian J Cancer; 1990 Sep; 27(3):143-53. PubMed ID: 2090566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Exclusive radical radiotherapy of laryngeal tumors: 10-year experience].
    Basilico L; Taraborrelli M; Laudadio L; Nuzzo A; Basilico NF; Peretti G; D'Alessandro M; Neri G; Croce A
    Radiol Med; 1997; 94(1-2):90-3. PubMed ID: 9424659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.